Meta Information

ID:simvastatin

Name:Simvastatin

Schema Version:1.5

Alternate Names

• Zocor

Intervention Type

therapeutic_agent

Expected Cost Mean

Low Cost:

5

High Cost:

25

Cost Type:

monthly

Description:

Widely available generic prescription, often covered by insurance.

Summary

Simvastatin is an HMG-CoA reductase inhibitor that lowers the production of cholesterol in the liver. Its primary healthspan relevance is the profound reduction of atherosclerotic cardiovascular disease (ASCVD) risk, a leading driver of mortality and morbidity in aging populations.

Purpose

Lowers LDL cholesterol to reduce risk of cardiovascular disease.

Card Summary

A statin medication that lowers LDL cholesterol, a primary driver of atherosclerosis.

Drug Class

statins

Drugs In Class

Empty Array

Impact

Score:

8.5

Justification:

Dramatically reduces risk of cardiovascular events, a leading cause of age-related mortality.

Evidence

Grade:

A

Score:

10

Justification:

Extensive, high-quality human RCTs and meta-analyses confirm major cardiovascular risk reduction.

Safety

Score:

5.5

Justification:

Generally well-tolerated but carries risks of myopathy and new-onset diabetes.

Flags

• Risk of muscle pain (myalgia) and, rarely, severe muscle damage (rhabdomyolysis).
• Associated with a small but statistically significant increased risk of developing type 2 diabetes.
• Interacts with grapefruit juice and certain medications like fibrates and some antifungals.
• Requires a prescription and medical supervision for use.

Verdict

A foundational tool for managing cardiovascular risk, a key longevity pillar.

Created

2026-04-27T00:50:29.486633Z

Model

Gemini 3.1 Pro (High)

Delivery

Route:

oral

Scope:

• systemic

Indication

Focus:

disease_treatment

Description:

Simvastatin is an HMG-CoA reductase inhibitor that lowers the production of cholesterol in the liver. Its primary healthspan relevance is the profound reduction of atherosclerotic cardiovascular disea...

Typical Protocol

• Daily dosages of 10-40 mg are common for managing hyperlipidemia under medical supervision.